103 related articles for article (PubMed ID: 21357302)
1. Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Ananda-Rajah MR; Cheng A; Morrissey CO; Spelman T; Dooley M; Neville AM; Slavin M
Antimicrob Agents Chemother; 2011 May; 55(5):1953-60. PubMed ID: 21357302
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting.
Kaskel P; Tuschy S; Wagner A; Bannert C; Cornely OA; Glasmacher A; Lipp HP; Ullmann AJ
Ann Hematol; 2008 Apr; 87(4):311-9. PubMed ID: 17929018
[TBL] [Abstract][Full Text] [Related]
3. Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study.
Neoh CF; Chen SCA; Kong DCM; Hamilton K; Nguyen QA; Spelman T; Tew M; Harvey EL; Ho SA; Saunders NR; Tennakoon S; Crowe A; Marriott D; Trubiano JA; Slavin MA
J Antimicrob Chemother; 2024 Jan; 79(1):46-54. PubMed ID: 37944018
[TBL] [Abstract][Full Text] [Related]
4. High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies.
Mori G; Diotallevi S; Farina F; Lolatto R; Galli L; Chiurlo M; Acerbis A; Xue E; Clerici D; Mastaglio S; Lupo Stanghellini MT; Ripa M; Corti C; Peccatori J; Puoti M; Bernardi M; Castagna A; Ciceri F; Greco R; Oltolini C
Microorganisms; 2024 Jan; 12(1):. PubMed ID: 38257945
[TBL] [Abstract][Full Text] [Related]
5. Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer.
Bossù G; Di Sario R; Muratore E; Leardini D; Pession A; Esposito S; Masetti R
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289974
[TBL] [Abstract][Full Text] [Related]
6. A New Filter Based Cultivation Approach for Improving Aspergillus Identification using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).
Salah H; Kolecka A; Rozaliyani A; Wahyuningsih R; Taj-Aldeen SJ; Boekhout T; Houbraken J
Mycopathologia; 2022 Feb; 187(1):39-52. PubMed ID: 35006478
[TBL] [Abstract][Full Text] [Related]
7. Adherence to Antifungal Guidelines in Malignant Hematology Patients: A Review of the Literature.
Reslan Z; Lindsay J; Kerridge I; Gellatly R
J Pharm Technol; 2019 Dec; 35(6):270-280. PubMed ID: 34753155
[No Abstract] [Full Text] [Related]
8. Spatial pattern of genetic diversity in field populations of
Rampersad SN
Ecol Evol; 2021 Jul; 11(13):9010-9020. PubMed ID: 34257941
[No Abstract] [Full Text] [Related]
9. Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients.
Costantini C; Nunzi E; Spolzino A; Palmieri M; Renga G; Zelante T; Englmaier L; Coufalikova K; Spáčil Z; Borghi M; Bellet MM; Acerbi E; Puccetti M; Giovagnoli S; Spaccapelo R; Talesa VN; Lomurno G; Merli F; Facchini L; Spadea A; Melillo L; Codeluppi K; Marchesi F; Marchesini G; Valente D; Dragonetti G; Nadali G; Pagano L; Aversa F; Romani L
Infect Immun; 2021 Jul; 89(8):e0010521. PubMed ID: 33782152
[TBL] [Abstract][Full Text] [Related]
10. Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study.
Tanpaibule T; Jinawath N; Taweewongsounton A; Niparuck P; Rotjanapan P
Infect Dis Ther; 2020 Dec; 9(4):807-821. PubMed ID: 32860206
[TBL] [Abstract][Full Text] [Related]
11. A consensus document for the clinical management of invasive fungal diseases in pediatric patients with hematologic cancer and/or undergoing hematopoietic stem cell transplantation in Brazilian medical centers.
Carlesse F; Daudt LE; Seber A; Dutra ÁP; Melo ASA; Simões B; Macedo CRD; Bonfim C; Benites E; Gregianin L; Batista MV; Abramczyk M; Tostes V; Lederman HM; Lee MLM; Loggetto S; Galvão de Castro Junior C; Colombo AL
Braz J Infect Dis; 2019; 23(6):395-409. PubMed ID: 31738887
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Dialytic Clearance of Isavuconazole During In Vitro and In Vivo Continuous Renal Replacement Therapy.
Biagi M; Butler D; Tan X; Qasmieh S; Tejani K; Patel S; Rivosecchi RM; Nguyen MH; Clancy CJ; Shields RK; Wenzler E
Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31527035
[TBL] [Abstract][Full Text] [Related]
13. Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus.
Jiang W; Withers B; Sutrave G; Clancy LE; Yong MI; Blyth E
Curr Hematol Malig Rep; 2019 Aug; 14(4):247-260. PubMed ID: 31228095
[TBL] [Abstract][Full Text] [Related]
14.
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical stability of voriconazole in elastomeric devices.
Harmanjeet H; Zaidi STR; Ming LC; Wanandy T; Patel RP
Eur J Hosp Pharm; 2018 Oct; 25(e2):e88-e92. PubMed ID: 31157075
[TBL] [Abstract][Full Text] [Related]
16. Toward Electronic Surveillance of Invasive Mold Diseases in Hematology-Oncology Patients: An Expert System Combining Natural Language Processing of Chest Computed Tomography Reports, Microbiology, and Antifungal Drug Data.
Ananda-Rajah MR; Bergmeir C; Petitjean F; Slavin MA; Thursky KA; Webb GI
JCO Clin Cancer Inform; 2017 Nov; 1():1-10. PubMed ID: 30657390
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
Wang Y; Xing Y; Chen L; Meng T; Li Y; Xie J; Chen L; Dong Y; Dong W
Int J Hematol; 2018 Feb; 107(2):235-243. PubMed ID: 29027638
[TBL] [Abstract][Full Text] [Related]
18. Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice.
Rambaldi B; Russo D; Pagano L
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017012. PubMed ID: 28101316
[No Abstract] [Full Text] [Related]
19. Identification of Molds by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
Sanguinetti M; Posteraro B
J Clin Microbiol; 2017 Feb; 55(2):369-379. PubMed ID: 27807151
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic and treatment cost of invasive fungal infections in patients with hematologic malignancies during hospitalization].
Ji Y; Sun YQ; Huang H; Chen J; Zhang XY; Meng FY; Han MZ; Wu DP; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):819-822. PubMed ID: 27719729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
